United Therapeutics Chairperson, CEO Martine Rothblatt disposes of USD 4.63 million in common shares

United Therapeutics Corporation

United Therapeutics Corporation

UTHR

0.00
  • United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised options for 9,500 common shares at USD 146.03 on May 28, 2026.
  • Rothblatt sold 9,500 common shares on May 28, 2026 at weighted-average prices from USD 561.53 to USD 571.55.
  • Direct common shares held fell to 40,513 following the transactions.
  • Direct stock options held rose to 145,410 following the option exercise.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000064), on May 29, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.